CD276 and breast carcinoma: miR-601 has been shown to be a diagnostic serum biomarker for colorectal cancer [44] and has been found to target and downregulate B7-H3, a immunoregulatory protein associated with poor prognosis and metastasis in several cancers and in breast cancer cell lines [41].